Jason Hoitt - Jun 18, 2025 Form 3 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Chief Patient Officer
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Jun 18, 2025
Transactions value $
$0
Form type
3
Date filed
6/23/2025, 04:16 PM
Previous filing
Apr 27, 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoitt Jason Chief Patient Officer C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD /s/ Jonathan Allan, Attorney-in-Fact 2025-06-23 0001762572

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding STOK Common Stock 1.8K Jun 18, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding STOK Employee Stock Option (Right to Buy) Jun 18, 2025 Common Stock 265K $12.21 Direct F1
holding STOK Employee Stock Option (Right to Buy) Jun 18, 2025 Common Stock 65K $14.25 Direct F2
holding STOK Employee Stock Option (Right to Buy) Jun 18, 2025 Common Stock 60K $8.33 Direct F3
holding STOK Employee Stock Option (Right to Buy) Jun 18, 2025 Common Stock 90K $11.70 Direct F4
holding STOK Restricted Stock Units Jun 18, 2025 Common Stock 40K Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/4 of the total award on April 8, 2025, with another 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F2 The option shall vest as to 1/4 of the total award on August 15, 2025, with another 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F3 The option vested or vests as to 1/48 of the total award on April 15, 2025, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F4 The option vested or vests as to 1/48 of the total award on July 16, 2025, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F5 The award shall vest as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the issuer through each vesting date.
F6 Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock upon settlement.